Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • National...

    Tag: national pharmaceutical pricing authority

    You Searched For "National Pharmaceutical Pricing Authority"
    Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;

    Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;

    Farhat Nasim7 Aug 2019 5:30 PM IST
    New Delhi: After fixing the prices of various stents including cardiac stents and orthopaedic implants and even cancer drugs, the government is soon...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug

    DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug

    Farhat Nasim18 July 2019 3:58 PM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals has rejected the review application filed by Mylan Pharmaceuticals Private...
    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Meghna A Singhania23 Jun 2019 4:57 PM IST
    New Delhi: Allowing the review petition of Zydus Healthcare Limited regarding price fixation of Tiotropium Inhalation (MDI) 9 mcg/dose, the Department...
    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Farhat Nasim16 Jun 2019 11:44 AM IST
    New Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 5:44 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    Meghna A Singhania6 May 2019 11:23 AM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    NPPA fixes retail price of 20 drugs including FDCs for Blood pressure control, dual antiplatelet

    NPPA fixes retail price of 20 drugs including FDCs for Blood pressure control, dual antiplatelet

    Meghna A Singhania4 May 2019 12:31 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Prices of 21 New Drugs fixed by NPPA; Details

    Prices of 21 New Drugs fixed by NPPA; Details

    Meghna A Singhania4 April 2019 10:00 AM IST
    The NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla,...
    Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

    Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

    Meghna A Singhania2 April 2019 12:34 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling...
    Price Fixation: NPPA revises ceiling price of 8 IV fluids including Glucose; Details

    Price Fixation: NPPA revises ceiling price of 8 IV fluids including Glucose; Details

    Meghna A Singhania2 April 2019 11:45 AM IST
    NEW DELHI: Through a recent official release, National Pharmaceutical Pricing Authority (NPPA) has informed about the revision in the ceiling price of...
    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Meghna A Singhania17 March 2019 1:33 PM IST
    New Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok